Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -782 | -3,004 | -2,334 | -1,737 | -795 |
| Depreciation Amortization | 2 | 15 | 11 | 8 | 4 |
| Accounts receivable | 133 | -174 | -125 | 20 | -70 |
| Other Working Capital | 155 | 1,369 | 1,250 | 1,124 | 423 |
| Other Operating Activity | -27 | 423 | 327 | 128 | 231 |
| Operating Cash Flow | $-520 | $-1,371 | $-870 | $-459 | $-207 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -20 | -20 | -20 | -20 |
| Other Investing Activity | 0 | 2 | 2 | 0 | 0 |
| Investing Cash Flow | $N/A | $-18 | $-18 | $-20 | $-20 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 505 | 1,700 | 1,125 | 470 | 200 |
| Other Financing Activity | 0 | -265 | -265 | 0 | 0 |
| Financing Cash Flow | $505 | $1,435 | $860 | $470 | $200 |
| Beginning Cash Position | 74 | 29 | 29 | 29 | 29 |
| End Cash Position | 60 | 74 | 1 | 20 | 2 |
| Net Cash Flow | $-15 | $46 | $-28 | $-8 | $-27 |
| Free Cash Flow | |||||
| Operating Cash Flow | -520 | -1,371 | -870 | -459 | -207 |
| Capital Expenditure | N/A | -20 | -20 | -20 | -20 |
| Free Cash Flow | -520 | -1,391 | -890 | -478 | -227 |